Trials / Completed
CompletedNCT00660244
Breast Cancer Tumor Care Observational Programme
Breast Cancer Tumor Care Patient Observation Programme
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate efficacy and tolerability under anastrozole (Arimidex) treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | anastrozole | Oral |
Timeline
- Start date
- 2008-02-01
- Completion
- 2009-12-01
- First posted
- 2008-04-17
- Last updated
- 2012-06-06
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT00660244. Inclusion in this directory is not an endorsement.